Comparing Two Indirect Pulp Capping Agents for Permanent Teeth

June 15, 2022 updated by: Marwa Ahmed Ahmed Zaghloul, Cairo University

Clinical and Radiographic Evaluation of Silver Diamine Fluoride Versus Mineral Trioxide Aggregate as Indirect Pulp Capping Agents in Deeply Carious Young Permanent Molars Randomized Controlled Clinical Trial

Aim of the study:

To evaluate clinical and radiographic success rates of silver diamine fluoride versus mineral trioxide aggregate as indirect pulp capping agents in deeply carious young first permanent molars.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Indirect pulp treatment has become a common maneuver in vital pulp therapy in recent years and is a procedure performed in teeth with deep carious lesions approximating the pulp but without any signs or symptoms of irreversible pulpal changes.

Silver Diamine Fluoride is used to arrest caries lesions in primary teeth but according to the AAPD,2021 more research is needed on the use of SDF to arrest caries lesions in permanent teeth.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 14 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient and parent showing cooperation and compliance.
  • Children 9-14 years old
  • Vital deeply carious young first permanent molar(s) with complete root formation
  • Asymptomatic teeth or without clinical symptoms of spontaneous pain
  • Both genders will be included.

Exclusion Criteria:

  • Children unable to return for recall visits.
  • Any clinical signs of irreversible pulpitis or pulp necrosis (spontaneous pain, pain on percussion, abscess, sinus).
  • Any radiographic sign of irreversible pulp pathologies or pulp necrosis (periapical radiolucency, internal or external root resorption)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: silver diamine fluoride group
partial caries removal will be carried out then Silver Diamine Fluoride will be applied as indirect pulp capping agent and rubbed for 1 minute followed by Glass ionomer filling
First permanent molars in this group will receive 38% silver diamine fluoride as an indirect pulp capping material.
Other Names:
  • SDF
Active Comparator: mineral trioxide aggregate group
partial caries removal will be carried out then mineral trioxide aggregate will be placed as indirect pulp capping agent followed by glass ionomer filling
First permanent molars in this group will receive mineral trioxide aggregate as an indirect pulp capping material.
Other Names:
  • MTA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dentin bridge formation
Time Frame: 6 months
Dentin bridge formation will be measured in millimeters on standardized digital radiographs taken by Digital Radiographic examination
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain
Time Frame: 1 week
Postoperative pain will be assessed by questioning the patient or the guardian whether there is postoperative pain or not, Binary (yes or no)
1 week
Absence of sinus or fistula
Time Frame: 3 months
Intraoral Visual examination will be carried out to assess if there is a sinus or fistula, Binary (present/absent)
3 months
Absence of sinus or fistula
Time Frame: 6 months
Intraoral Visual examination will be carried out to assess if there is a sinus or fistula, Binary (present/absent)
6 months
radiographic success
Time Frame: 6 months
Absence of any adverse radiographic findings (Periodontal membrane space widening, bone resorption, pulp stones will be assessed if present or absent by digital radiographic examination, Binary (present or absent)
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Manal Ahmed El Sayed, Professor of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University
  • Principal Investigator: Randa Youssef Abd Al Gawad, Professor of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 1, 2022

Primary Completion (Anticipated)

October 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

June 14, 2022

First Submitted That Met QC Criteria

June 15, 2022

First Posted (Actual)

June 21, 2022

Study Record Updates

Last Update Posted (Actual)

June 21, 2022

Last Update Submitted That Met QC Criteria

June 15, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Indirect pulp capping

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deep Caries

Clinical Trials on Silver diamine fluoride

3
Subscribe